Background Breast cancer is the 5th leading cause of cancer death in Iranian women. This study analyzed 3010 women with breast cancer that had been referred to a cancer research center in Tehran between 1998 and 2014. Methods In this retrospective study, we analyzed 3010 breast cancer cases with 32 clinical and paraclinical attributes. We checked the data quality rigorously and removed any invalid values or records. The method was data mining (problem definition, data preparation, data exploration, modeling, evaluation, and deployment). However, only the descriptive analyses' results of the variables are presented in this article. To our knowledge, this is the most comprehensive study on breast cancer status in Iran. Results A typical Iranian breast cancer patient has been a 40–50-year-old married woman with two children, who has a high school diploma and no history of abortion, smoking, or diabetes. Most patients were estrogen and progesterone receptor positive, human epidermal growth factor (HER) negative, and P53 negative. Most cases were detected in stage 2 with intermediate grade. Conclusion This study revealed original findings which can be used in national policymaking to find the best early detection method and improve the care quality and breast cancer prevention in Iran.
Background: Mastectomy is sometimes performed in transgender patients, which may damage the regional nerves such as the pectoral and intercostobrachial nerves, leading to postoperative pain. An ultrasound-guided nerve block can be used to track and block the nerves properly. Objectives: This study aimed to compare the ultrasound-guided type-II pectoral nerve block with the blind (conventional) intercostal nerve block (ICNB) for pain control after breast tissue reconstruction surgery in transgender patients. Methods: In the present single-blind randomized clinical trial, 47 patients were randomly divided into two groups: (A) Ultrasound-guided type-II pectoral nerve block (n = 23) and (B) blind intercostal nerve block (n = 24). After nerve block in both groups, pain intensity at 3, 6, 12, and 24 hours after surgery, upper limb paresthesia, frequency of nausea and vomiting, shortness of breath, hematoma, and the length of hospital stay were assessed. Results: Patients who received the ultrasound-guided type-II pectoral nerve block had a greater reduction in pain intensity (24 h after surgery), opioid use (24 h after surgery), nausea, vomiting, and hospital stay than those who received ICNB, whereas the recovery time did not differ between the study groups. Conclusions: The pectoral nerve block under ultrasound guidance, compared to the intercostal nerve block, in transgender patients can reduce the required dosage of opioids within 24 hours, pain intensity within 24 hours after surgery, the incidence of postoperative nausea, and vomiting, and the hospital stay of patients.
Background: Breast cancer treatment success depends upon prolonging survival with effective treatment, and constant monitoring of recurrence. Survival rate can well be improved by better understanding of prognostic factors, preventive measures, and effective treatments together with follow-up and post-treatment care.
Objective: Breast cancer is the most common cancer in American women, except for skin cancers. In this metaanalysis, the associations of polymorphisms within paraoxonase 1 (PON1), leptin (LEP) and leptin receptor (LEPR) genes with susceptibility to breast cancer were comprehensively evaluated. Methods: A universal search in PubMed, Scopus, CNKI, SID, Web of Knowledge and Google Scholar was performed to identify relevant studies up to 01 May, 2021. The strength of the associations was estimated by Odds ratios (ORs) with 95% confidence intervals (95% CIs). Results: A total of 39 case-control studies including 7 studies with 2005 cases and 2748 controls were on PON1 rs662, 6 studies with 2,031 cases and 1,973 controls on PON1 rs854560, 12 studies with 3,444 cases and 3,583 controls on LEP rs7799039, and 14 studies with 5,330 cases and 6,188 controls on LEPR rs1137101 were selected. Pooled data showed that PON1 rs662 and rs854560 polymorphisms were associated with risk of breast cancer in overall population, but not LEP rs7799039 and LEPR rs1137101. Conclusions: Our pooled data revealed that the PON1 rs662 and rs854560 polymorphisms were significantly associated with an increased risk of breast cancer in the overall population. However, LEP rs7799039 and LEPR rs1137101 polymorphisms were not associated.
Aims:
This study aims to design an angiogenesis gene expression profile; to study angiogenesis gene
expression profile in breast cancer; and to map angiogenesis gene expression profile in individual participants.
Background:
In molecular etiology of each disease, there are some important molecules involved in the
related pathways. From the viewpoint of precision medicine, molecular etiology of a disease is different
person by person because of genetic variations of the genes involved in these pathways. This point of view
intends researchers of drug development to design novel drugs for targeted therapy based on the exact etiology.
In the case of angiogenesis, there is a drug profile parallel to the molecular profile. Bevacizumab,
sunitinib and aflibercept are examples of anti-angiogenic drugs.
Objectives:
A hallmark of solid tumors is sustained angiogenesis. Vascular endothelial growth factors
(VEGF), VEGF receptors (VEGFR) and placental growth factor (PlGF) are involved in angiogenesis. We
aimed to study the gene expression profile of angiogenesis including VEGF-A, VEGF-B, VEGF-C,
VEGF-D, VEGFR-1, VEGFR-2, VEGFR-3 and PlGF in an Iranian group of patients undergoing breast
surgery due to breast cancer and breast fibroadenoma.
Methods:
Tumor tissue samples of a group of patients with invasive ductal carcinoma (IDC) and a group
of patients with fibroadenoma (Fib) were used. Gene expression was studied by real-time quantitative
polymerase chain reaction (q-PCR) and fold changes (FC) with their 95% confidence intervals (CI) were
reported based on calibration with normal breast tissue.
Results:
All the genes showed significant up-regulation in IDC group. The extensive up-regulation was
for VEGFR-2 (FC=52.68; 95% CI=17.96-154.47; P<0.001). In Fib group, PlGF showed a significant upregulation
(FC=10.41; 95% CI=5.35-20.26; P=0.002). Comparison of IDC group with Fib group showed
significant up-regulation of VEGFR-1, VEGFR-2 and VEGFR-3 in IDC group (P<0.05).
Conclusion:
Malignancy of breast tumors is associated with overexpression of all the genes of this profile.
However, only VEGFRs showed up-regulation in comparison to benign tumors. Individualized targeted
therapy, according to this profile, should be studied in the future.
6 Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. British 7 Anbari K, Ahmadi SAY, Baharvand P, Sahraei N. Investigation of breast cancer screening among the women of Khorramabad (west of Iran): a cross-sectional study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.